RetiSpec
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
220 Joicey Blvd, Toronto, Ontario, M5M 2...Website
www.retispec.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RetiSpec
RetiSpec Inc. is a medical imaging company developing a tool for the early detection of Alzheimer's disease biomarkers in the eye using machine learning. RetiSpec's test is noninvasive, simple to administer and inexpensive compared to current practices. This advantage of accessible and scalable screening enables widespread early detection of Alzheimer's disease pathology. The company is headquartered in Toronto, and is part of the Ontario Brain Institute (OBI), Biomedical Zone, NEXT Canada, Ontario Centre of Excellence and The Centre for Aging and Brain Health Innovation (CABHI)'s network of companies.Explore more
RetiSpec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RetiSpec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once RetiSpec has new funding data
Click to see if RetiSpec had a recent Job posting/layoffs
Earning: See what the market has to say on RetiSpec recently announced quarterly report
RetiSpec, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when RetiSpec launches new products
Check out if RetiSpec is spiking on competitors!
Check if RetiSpec has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at RetiSpec
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at RetiSpec
Find more new buyers
Compare Similar Companies to RetiSpec
Compare insights from companies similar to RetiSpec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RetiSpec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RetiSpec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RetiSpec.
RetiSpec financials insights
Gather financial insights about RetiSpec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$10M
RetiSpec Tech Stack
A closer look at the technologies used by RetiSpec
RetiSpec News & Media
RetiSpec secures $13.8 million Series A to detect Alzheimer’s early through retinal imaging
American pharmaceutical giant Eli Lilly and medical device provider Topcon Healthcare join as strategic investors. The post RetiSpec secures $13.8 million Series A to detect Alzheimer’s early through retinal imaging first appeared on BetaKit.RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease
TORONTO, July 26, 2024 /PRNewswire/ - RetiSpec Inc., an innovator in AI-driven eye diagnostics for brain health, announced the successful closing of its $10M USD Series A financing. This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology...RetiSpec,Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
Companies aim to expedite the commercialization of technology designed to detect risks to brain health through imaging of the retina TORONTO, April 30, 2024 /PRNewswire/ - RetiSpec, Inc., an innovator in AI-powered eye diagnostics for brain health, and Topcon Healthcare, Inc. a leading...RETISPEC AND TORONTO MEMORY PROGRAM AWARDED GRANT TO LAUNCH INNOVATIVE EARLY DETECTION PROGRAM FOR ALZHEIMER'S IN TORONTO, CANADA
RetiSpec and Toronto Memory Program are One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer's Collaborative Grant Program for Healthcare System Preparedness TORONTO, May 25, 2022 /PRNewswire/ -- Toronto Memory Program and RetiSpec today announced the launch of a unique...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding RetiSpec
Sign Up For FreeTo access detailed company insights
RetiSpec Inc. is a medical imaging company developing a tool for the early detection of Alzheimer's disease biomarkers in the eye using machine learning. RetiSpec's test is noninvasive, simple to administer and inexpensive compared to current practices. This advantage of accessible and scalable screening enables widespread early detection of Alzhei... Read More
